Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000521278 | SCV000617655 | pathogenic | not provided | 2022-09-15 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In-frame deletion of 1 amino acid in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23714322, 11281458, 32581362, 30825406) |
Invitae | RCV000521278 | SCV001556677 | pathogenic | not provided | 2022-12-22 | criteria provided, single submitter | clinical testing | This variant, c.952_954del, results in the deletion of 1 amino acid(s) of the CACNA1F protein (p.Phe318del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 438129). This variant has been observed in individuals with congenital stationary night blindness (PMID: 11281458, 23714322, 30825406; Invitae). It has also been observed to segregate with disease in related individuals. |
Ce |
RCV000521278 | SCV002498133 | likely pathogenic | not provided | 2022-03-01 | criteria provided, single submitter | clinical testing | CACNA1F: PM2, PM3, PM4 |
NIHR Bioresource Rare Diseases, |
RCV000505132 | SCV000599049 | likely pathogenic | Congenital stationary night blindness | 2015-01-01 | no assertion criteria provided | research | |
Sharon lab, |
RCV002267736 | SCV001160955 | pathogenic | Cone-rod dystrophy | 2019-06-23 | no assertion criteria provided | research |